Skip to main content
. 2023 May 24;16(6):783. doi: 10.3390/ph16060783

Figure 2.

Figure 2

NF-κB functions in several types of PCD containing apoptosis, necroptosis, pyroptosis, and ferroptosis. Black solid arrows represent facilitation and blue dashed arrows represent inhibition. TNFR, TNF receptor; FLIP, FLICE-inhibitory protein; MnSOD, manganese superoxide dismutase; FHC, ferritin-heavy chain; RIPK1, receptor-interacting protein kinase 1; TRADD, TNF receptor associated death domain; cIAP, cellular inhibitor of apoptosis protein; TRAF, TNF receptor associated factor; FADD, Fas-associated death domain; CYLD, cylindromatosis; MLKL, mixed lineage kinase domain-like pseudokinase; CXCR4, C-X-C chemokine receptor type 4; uPA, urokinase-type plasminogen activator; TAK1, transforming growth factor-β (TGF-β)-activated kinase 1; MAPK, mitogen-activated protein kinase; CXCL, C-X-C chemokine ligand; CCL20, chemokine C-C motif ligand 20; CSF1, colony-stimulating factor 1; TRIM, tripartite motif-containing; GM-CSF, granulocyte-macrophage colony-stimulating factor; 5-FU, 5-fluorouracil; GSDM, gasdermin; DRD2, D2 dopamine receptor; cytC, cytochrome C; AMPK, AMP-activated protein kinase; SIRT1, silent mating type in-formation regulation 2 homolog-1; GPX4, glutathione peroxidase 4; RSL3, RAS-selective lethal 3; SLC7A11, solute carrier family 7, Member 11; GSH, glutathione; GSSG, oxidized glutathione; DMF, dimethylformamide; NKAP, NF-κB activating protein; LCN2, Lipocalin 2; LIFR, leukemia-inhibitory factor receptor; SHP1, Src homology domain 2-containing protein tyrosine phosphatase 1; DFX, deferasirox; HMGB1, high mobility group box 1.